HDFC Pharma and Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
HDFC Pharma and Healthcare Fund - Regular (G)
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹233 Cr | ₹2011 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 08 Nov 2021 | 04 Oct 2023 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare Index |
| Turn Over | % | % |
| Expense Ratio | 2.35 | 2.14 |
| Manager | Rohan Korde | Dhruv Muchhal |
| ISIN Code | INF00XX01BL5 | INF179KC1HL7 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| 1 Month | -3.04% | -2.02% |
| 6 Month | -3.84% | 2.48% |
| 1 Year | -7.85% | 4.71% |
| 3 Year | 18.83% | - |
| 5 Year | - | - |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| 6 Month | -3.25% | -0.32% |
| 1 Year | -1.61% | 9.85% |
| 3 Year | 13.79% | - |
| 5 Year | - | - |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| 1 Year | 18.94% | 27.59% |
| 3 Year | 20.21% | - |
| 5 Year | - | - |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Standard Deviation | 15.68% | - |
| Sharp | 0.75% | - |
| Beta | 0.95% | - |
| Alpha | -3.33% | - |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Name | Rohan Korde | Dhruv Muchhal |
| Total AUM | ₹4626 Cr | ₹520687 Cr |
| Funds Managed | 10 | 40 |
| ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Others | 3.94 | 10.09 |
| Large Cap | 32.04 | 26.1 |
| Mid Cap | 36.31 | 30.15 |
| Small Cap | 27.72 | 33.66 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Others | 1.7 | 1.71 |
| Healthcare | 93.14 | 95.43 |
| Basic Materials | 2.87 | 2.86 |
| Industrials | 1.05 | - |
| Financial Services | 1.25 | - |
Top Comparisons
Tata Equity Savings Fund -Regular Plan-Growth Option
3Y Returns9.81%
Axis Equity Savings Fund - Regular Plan - Growth
3Y Returns10.01%
SBI Arbitrage Opportunities Fund - Regular Plan - Gr
3Y Returns7.18%
Mirae Asset Arbitrage Fund Regular Growth
3Y Returns6.92%
HDFC Retirement Savings Fund - Equity Plan - Growth Option
3Y Returns17.4%
SBI Retirement Benefit Fund - Aggressive Plan - Regular Plan - Growth
3Y Returns12.8%
Sundaram Short Duration Fund Regular Growth
3Y Returns7.32%
Mirae Asset Short Duration Fund- Regular Plan -Growth
3Y Returns7.04%